Biotechnology Value Fund L P - Nov 20, 2025 SCHEDULE 13D/A Report for Repare Therapeutics Inc. Common Shares, no par value (RPTX)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Repare Therapeutics Inc. Common Shares, no par value
Symbol
RPTX
Shares outstanding
43.1M shares
Disclosed Ownership
10.3M shares
Ownership
24%
Form type
SCHEDULE 13D/A
Date filed
11/24/2025, 05:05 PM
Date of event
Nov 20, 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 12.4% 5.31M 0 5.31M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0000918923
BVF I GP LLC 12.4% 5.31M 0 5.31M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803805
BIOTECHNOLOGY VALUE FUND II LP 10% 4.31M 0 4.31M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001102444
BVF II GP LLC 10% 4.31M 0 4.31M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803806
Biotechnology Value Trading Fund OS LP 1.3% 549K 0 549K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660683
BVF Partners OS Ltd. 1.3% 549K 0 549K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660684
BVF GP HOLDINGS LLC 22.4% 9.62M 0 9.62M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803809
BVF PARTNERS L P/IL 24% 10.3M 0 10.3M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001055947
BVF INC/IL 24% 10.3M 0 10.3M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001056807
LAMPERT MARK N 24% 10.3M 0 10.3M /s/ Mark N. Lampert Mark N. Lampert 0001233840